NATION-WIDE SURVEY ON THE USE OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RA) FOR THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA IN CURRENT CLINICAL PRACTICE IN ITALY. Mediterr J Hematol Infect Dis [Internet]. 2023 Feb. 28 [cited 2026 Apr. 18];15(1):e2023019. Available from: https://www.mjhid.org/mjhid/article/view/5236